Back to results
US 2008/0293686 A1Published application
Semi-solid systems containing azetidine derivatives
AssigneeAventis Pharma S.A.
InventorsMaria-Teresa PERACCHIA, Sophie COTE, Valerie BOBINEAU
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel formulations of azetidine derivatives for oral administration comprising at least one azetidine compound of formula (Ia) or (Ib): in a system comprising a Vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate polymeric semi-solid material.
Claims9
A stable pharmaceutical composition comprising at least one azetidine compound of formula (Ia) or (Ib):
- in which Ar is an aromatic or heteroaromatic group optionally substituted with one or more (C1-C4)alkyl, halogen, NO2, CN, (C1-C4)alkoxy or OH groups, in a system comprising a Vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) polymeric semi-solid material.
Dependencies are inferred from the claim text.